PubMed چکیده/رکورد

In Silico CRISPR Restoration of F7 Promoter Activity in Hereditary Factor VII Deficiency.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

Hereditary Factor VII (FVII) deficiency is associated with reduced F7 gene expression and impaired coagulation, and regulatory mechanisms controlling F7 transcription remain incompletely characterized. This study aimed to computationally explore whether restoration of predicted HNF4α binding at the F7 promoter, through transcription factor modulation, promoter motif correction, or CRISPR activation (CRISPRa)-mediated epigenetic regulation, could theoretically enhance predicted F7 transcription in hereditary FVII deficiency. An entirely in silico pipeline was developed to characterize the F7 promoter regulatory landscape by identifying conserved transcription factor binding motifs using JASPAR, FIMO, and UCSC Genome Browser datasets. Liver expression correlations were evaluated using GTEx transcriptomic data, while chromatin accessibility and regulatory context were assessed using ENCODE ChIP-seq, ATAC-seq, and ChromHMM/Segway annotations. A hepatic regulatory network was constructed in CellDesigner to simulate the predicted effects of HNF4α loss on F7 transcription over a 24-h period. Six high-confidence HNF4α binding motifs were identified within the proximal F7 promoter, including three regions overlapping known disease-associated variants. Liver expression analyses demonstrated positive correlations between F7 and HNF4A (r = 0.68) and HNF1A (r = 0.61). Computational modeling predicted that CRISPRa targeting of HNF4α-associated regulatory regions could increase simulated F7 transcription toward approximately 87% of wild-type levels under the modeled conditions, with predicted target specificity. Overall, this purely computational study presents an integrated multi-omic framework for prioritizing promoter-targeted regulatory strategies in hereditary FVII deficiency. By combining transcription factor motif analysis, chromatin annotation, transcriptomic correlation, regulatory network modeling, and CRISPR guide prioritization within a unified pipeline, the study generates experimentally testable hypotheses while providing a systematic approach that extends beyond previous single-variant or isolated experimental analyses.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2027

Clinical Flow Cytometric Testing in Chronic Lymphocytic Leukemia.

Flow cytometry is the cornerstone for establishing the diagnosis of chronic lymphocytic leukemia (CLL), owing to its characteristic and well-defined immunophenotype that enables accurate distinction from other leukemias and lymphomas. Beyond diagnosis, flow cytometry provides essential prognostic information and allows sensitive detection of minimal residual disease (MRD), a strong predictor of clinical outcome. CLL MRD assessment is i…

PubMed2027

Flow Cytometric Immunophenotyping of Acute Lymphoblastic Leukemia.

Immunophenotyping by flow cytometry is an important component in the diagnostic evaluation of patients with acute lymphoblastic leukemia. This technique further permits the detection of minimal residual disease after therapy, a robust prognostic factor that may guide individualized treatment. We describe here laboratory methods for both the initial characterization of lymphoblasts at diagnosis and the detection of rare leukemic lymphob…

PubMed2027

Immunophenotyping of Acute Myeloid Leukemia.

Immunophenotyping by multiparameter flow cytometry is a rapid and efficient technique to simultaneously assess and correlate multiple individual cell properties like size and internal complexity along with antigen expression in a population of cells. This method is utilized for rapid characterization of the blasts and classification of acute myeloid leukemia (AML) in both the peripheral blood (PB) and bone marrow (BM). This technique i…

PubMed2027

Measurable Residual Disease.

Measurable residual disease (MRD) serves as a critical biomarker of prognosis, treatment efficacy, and clinical outcome. It captures the presence of residual tumor cells below the detection threshold of conventional microscopy. Multiparametric flow cytometry (MFC) offers a rapid, cost-efficient, and widely applicable platform for MRD detection through leukemia-associated immunophenotypes (LAIPs) and deviation-from-normal (DfN) antigen …